About Beijing Yimiao Shenzhou Pharmaceutical Technology
Beijing Yimiao Shenzhou Pharmaceutical Technology is a company based in Haidian (China) founded in 2015.. Beijing Yimiao Shenzhou Pharmaceutical Technology has raised $42.81 million across 6 funding rounds from investors including GF Securities, Shengjing 360 and Zhongguancun Science City. Beijing Yimiao Shenzhou Pharmaceutical Technology operates in a competitive market with competitors including Jazz Pharmaceuticals, Insitro, BridgeBio, Celgene and ATAI, among others.
- Headquarter Haidian, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$42.81 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
GF Securities
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Beijing Yimiao Shenzhou Pharmaceutical Technology
Beijing Yimiao Shenzhou Pharmaceutical Technology has successfully raised a total of $42.81M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(24 Nov 2017)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series D - Beijing Yimiao Shenzhou Pharmaceutical Technology | Valuation | Zhongguancun Science City | |
| Nov, 2021 | Amount | Series D - Beijing Yimiao Shenzhou Pharmaceutical Technology | Valuation | China Life Insurance | |
| Dec, 2020 | Amount | Series C - Beijing Yimiao Shenzhou Pharmaceutical Technology | Valuation | SDIC Venture Capital Management |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beijing Yimiao Shenzhou Pharmaceutical Technology
Beijing Yimiao Shenzhou Pharmaceutical Technology has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include GF Securities, Shengjing 360 and Zhongguancun Science City. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
A European venture capital fund focused on deep tech investments.
|
Founded Year | Domain | Location | |
|
Private equity investments are managed from bases in China.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beijing Yimiao Shenzhou Pharmaceutical Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Beijing Yimiao Shenzhou Pharmaceutical Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beijing Yimiao Shenzhou Pharmaceutical Technology Comparisons
Competitors of Beijing Yimiao Shenzhou Pharmaceutical Technology
Beijing Yimiao Shenzhou Pharmaceutical Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Insitro, BridgeBio, Celgene and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Therapies for cancer and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Beijing Yimiao Shenzhou Pharmaceutical Technology
Frequently Asked Questions about Beijing Yimiao Shenzhou Pharmaceutical Technology
When was Beijing Yimiao Shenzhou Pharmaceutical Technology founded?
Beijing Yimiao Shenzhou Pharmaceutical Technology was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Beijing Yimiao Shenzhou Pharmaceutical Technology located?
Beijing Yimiao Shenzhou Pharmaceutical Technology is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.
Is Beijing Yimiao Shenzhou Pharmaceutical Technology a funded company?
Beijing Yimiao Shenzhou Pharmaceutical Technology is a funded company, having raised a total of $42.81M across 6 funding rounds to date.
What does Beijing Yimiao Shenzhou Pharmaceutical Technology do?
Beijing Yimiao Shenzhou Pharmaceutical Technology is a developer of AVV cell therapy for the treatment of cancer. It offers treatment for malignant tumors by the application of CART-T technology and gene cell drugs. It also develops a gene engineering vector technology platform for the delivery of lentiviral vectors for the preparation of CAR-T cell products. Its products include IM19, IM21, and IM23 which are in the clinical stage.
Who are the top competitors of Beijing Yimiao Shenzhou Pharmaceutical Technology?
Beijing Yimiao Shenzhou Pharmaceutical Technology's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and BridgeBio.
Who are Beijing Yimiao Shenzhou Pharmaceutical Technology's investors?
Beijing Yimiao Shenzhou Pharmaceutical Technology has 14 investors. Key investors include GF Securities, Shengjing 360, Zhongguancun Science City, Innovation Industries, and China Life Private Equity.